These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 5059372)

  • 41. The antiparkinsonian activity of monoamine oxidase inhibitors and other agents in rats and mice.
    Dandiya PC; Bhargava LP
    Arch Int Pharmacodyn Ther; 1968 Nov; 176(1):157-67. PubMed ID: 5709781
    [No Abstract]   [Full Text] [Related]  

  • 42. [Experiences with ethybenzatropine (Ponalid) in the treatment of Parkinson's syndrome].
    Avenarius HJ; Gerstenbrand F
    Wien Klin Wochenschr; 1969 Sep; 81(36):622-5 passim. PubMed ID: 5810005
    [No Abstract]   [Full Text] [Related]  

  • 43. The role of adrenergic mechanism in tremorine-induced tremors in rats: antitremor effect of beta-adrenoceptor antagonists.
    Paul V
    Indian J Physiol Pharmacol; 1986; 30(4):307-12. PubMed ID: 2883120
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Pharmacologic study of the possible anti-Parkinson effect of chlormethiazole].
    Lechat P; Streichenberger G
    Therapie; 1966; 21(6):1617-21. PubMed ID: 6002657
    [No Abstract]   [Full Text] [Related]  

  • 45. A comparative study of the effects of anti-parkinson drugs on the oxotremorine-induced EEG and muscular activities.
    Ban T; Hojo M
    Psychopharmacologia; 1971; 19(1):1-15. PubMed ID: 5089103
    [No Abstract]   [Full Text] [Related]  

  • 46. The effect of elantrine, a new anti-Parkinsonism agent, on drug-induced tremor in mice.
    Ursillo RC; McCulloch JA
    Arch Int Pharmacodyn Ther; 1972 May; 197(1):132-40. PubMed ID: 5031571
    [No Abstract]   [Full Text] [Related]  

  • 47. Nicotinic acetylcholine receptor alpha5 subunits modulate oxotremorine-induced salivation and tremor.
    Wang N; Orr-Urtreger A; Chapman J; Rabinowitz R; Korczyn AD
    J Neurol Sci; 2004 Jul; 222(1-2):87-91. PubMed ID: 15240201
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiparkinsonian-like effects of Plumbago scandens on tremorine-induced tremors methodology.
    Morais LC; Quintans-Júnior LJ; Franco CI; Almeida JR; Almeida RN
    Pharmacol Biochem Behav; 2004 Dec; 79(4):745-9. PubMed ID: 15582683
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Absence of anticholinergic activity of rolipram, an antidepressant with a novel mechanism of action, in three different animal models in vivo.
    Wachtel H; Löschmann PA; Pietzuch P
    Pharmacopsychiatry; 1988 Sep; 21(5):218-21. PubMed ID: 3227052
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of the pharmacological properties of deptropine, its methobromide--BS 7020a--and the 10,11-dehydro analogues.
    Timmerman H; Lavy UI; Mulder D
    Arch Int Pharmacodyn Ther; 1970 Oct; 187(2):291-300. PubMed ID: 4394744
    [No Abstract]   [Full Text] [Related]  

  • 51. 1-hydroxy-3-amino-pyrrolidone-2 (HA-966). II. Extrapyramidal aspects.
    Bonta IL; De Vos CJ; Grijsen H
    Arch Int Pharmacodyn Ther; 1969 Dec; 182(2):394-5. PubMed ID: 4984371
    [No Abstract]   [Full Text] [Related]  

  • 52. The effect of triflupromazine on the peripheral and central actions of some anticholinergic drugs.
    Brimblecombe RW; Green DM
    Br J Pharmacol; 1969 Feb; 35(2):P364-6. PubMed ID: 5774061
    [No Abstract]   [Full Text] [Related]  

  • 53. Centrally evoked responses by cholinergic agents and their antagonism by drugs in the conscious mouse.
    Ankier SI; Brittain RT; Handley SL
    Br J Pharmacol; 1968 Sep; 34(1):216P-217P. PubMed ID: 5676018
    [No Abstract]   [Full Text] [Related]  

  • 54. Tremorine-tremor, shivering and acute cerebellar ataxia in the adult and child--a comparative study.
    Brumlik J; Means ED
    Brain; 1969 Mar; 92(1):157-90. PubMed ID: 5774026
    [No Abstract]   [Full Text] [Related]  

  • 55. Dissociation of antitremorine activity and clinical antiparkinsonian effect. A clinical trial of AGN 511 in postencephalitic parkinsonism.
    Mattila MJ; Spiers AS; Sharkey J; Laurence DR
    Arzneimittelforschung; 1970 Dec; 20(12):1888-9. PubMed ID: 5537091
    [No Abstract]   [Full Text] [Related]  

  • 56. [Prolonged use of ponalid in extapyramidal drug-induced syndromes].
    Grabowski K
    Neurol Neurochir Psychiatr Pol; 1966 Dec; 16(12):1395-401. PubMed ID: 5973522
    [No Abstract]   [Full Text] [Related]  

  • 57. A rat model for Parkinsonian rest tremor.
    Tasker RR; Sogabe K
    Trans Am Neurol Assoc; 1973; 98():240-1. PubMed ID: 4784940
    [No Abstract]   [Full Text] [Related]  

  • 58. [On the effect of beta-adrenolytic substances on experimental static tremor].
    Stern P; Basagić E; Buljubasić S
    Wien Klin Wochenschr; 1969 Feb; 81(7):113. PubMed ID: 5784865
    [No Abstract]   [Full Text] [Related]  

  • 59. 3,5-Disubstituted-6-methyl-2-pyridone. Dihydrazide, dicarbamate, and monoaminoalkyl ester.
    Jaques B; Hubbard JW
    J Med Chem; 1972 Jun; 15(6):677-8. PubMed ID: 5030936
    [No Abstract]   [Full Text] [Related]  

  • 60. Acetylene compounds of potential pharmacological value. XVI. N-(perhydroazepinoalkynyl)- and N-(perhydroazocinoalkynyl)succinimides.
    Lindquist A; Lindgren S; Lindeke B; Karlén B; Dahlbom R; Blair MR
    Acta Pharm Suec; 1972 Apr; 9(2):93-8. PubMed ID: 5030544
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.